Eli Lilly releases a new ad called 'Big Night' to discourage the misuse of prescription medications developed for patients with Type 2 diabetes and obesity. The ad emphasizes that these drugs are not intended for general weight loss purposes and should only be used by those whose health is affected by obesity.
Eli Lilly has a message for people who are taking prescription medications developed for patients with Type 2 diabetes and obesity: Don't take the drugs just because you want to look good. The message, delivered in a new Hollywood-themed ad called ' Big Night ,' will air this weekend and is timed to coincide with Sunday's broadcast of the Oscars. The spot opens with a shot of a sequined gown, suggesting that the woman voicing the campaign is preparing for a formal event.
'Some people have been using medicine never meant for them. For the smaller dress or tux, for a big night, for vanity,' the character in the ad says. The camera then pans to a theater resembling the one in which the Academy Awards are handed out. The point is clear: Drugs like Lilly's Mounjaro or Novo Nordisk's Ozempic and Wegovy aren't intended for general weight loss. 'People whose health is affected by obesity are the reason we work on these medications. It matters who gets them,' the ad says. Mounjaro is used to treat patients with Type 2 diabetes
Eli Lilly Ad Big Night Prescription Medications Type 2 Diabetes Obesity Weight Loss Mounjaro Novo Nordisk Ozempic Wegovy
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk and Eli Lilly rival soars 35% after promising weight loss drug resultsZealand Pharma's Phase 2 trial was an 'uniquivocal win' for a drug that can treat both liver disease and obesity, analysts said.
Read more »
Eli Lilly's Alzheimer's drug delayed by FDA: ‘It was unexpected’On Friday, the FDA announced it would postpone a decision on Eli Lilly's potential Alzheimer's treatment donanemab.
Read more »
Eli Lilly's new ad says weight-loss drugs shouldn't be used out of 'vanity'In a new ad that nods to the 2024 Oscars, the pharmaceutical firm discourages people from using drugs like Mounjaro for cosmetic weight loss.
Read more »
Eli Lilly says Alzheimer’s drug approval delayed as FDA seeks input from advisersDrugmaker Eli Lilly says that approval of its experimental Alzheimer’s medication donanemab will be delayed beyond the end of March as the FDA plans to call a last-minute meeting of its advisers
Read more »
Stocks making the biggest moves midday: Nvidia, Marvell Technology, Costco, Eli Lilly and moreThese are the stocks posting the largest moves in midday trading.
Read more »
Eli Lilly's campaign seeks to resolve weight-loss drug misconceptionsEli Lilly is launching a campaign aimed at informing consumers about the seriousness of diabetes as a disease and the appropriate use of its weight-loss-related drugs.
Read more »